9 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Treatment Algorithm ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... #Anticoagulation
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Lower Extremity Venous ... Superficial - Active ... Superficial #Deep #VTE ... #Anatomy #Anticoagulation ... #Algorithm
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Unprovoked • Active ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... Unprovoked • Active ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... thrombosis; PE = pulmonary ... = venous thromboembolism ... #Anticoagulation ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... with Cardio-OB team ... suggest prophylactic anticoagulation ... Serial TTE and close ... #cardiology #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Intraabdominal - Orthopedic ... Anticoagulation ... • <3mo since VTE ... medical and surgical management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
WBCs are usually near-normal ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... (if history of venous ... hematology #diagnosis #management